Document
Rebate Reduction Requests ICR Crosswalk of Changes Between 2024 Final and CY 2027 Final Version Documents
ICR 202610-0938-010 · OMB 0938-1474 · Object 174199400.
Document Viewer [pdf]
Status: Original and derived artifacts are available for this document.
Download: pdf
Loading document viewer…
Document Metadata
| File Type | application/pdf |
|---|---|
| File Title | Rebate Reduction Requests ICR Crosswalk of Changes Between 2024 Final and CY 2027 Final Version Documents |
| Subject | Rebate Reduction Requests ICR Crosswalk of Changes Between 2024 Final and CY 2027 Final Version Documents |
| Keywords | Rebate Reduction Requests ICR Crosswalk of Changes Between 2024 Final and CY 2027 Final Version Documents |
| Author | CMS |
| Last Modified By | Acrobat PDFMaker 26 for Word |
| File Modified | 2026-10-29 |
| File Created | 2026-10-29 |
| Conversion State | complete |
Extracted Text
Rebate Reduction Requests ICR Crosswalk of Changes Between 2024 Final and CY 2027 Final Version Documents Location of Edits i Supporting Statement • • i Supporting Statement “Burden Estimates (Hours & Wages)” Supporting Statement “Cost to Federal Government” ICR Form (Appendix A, B, C and D), General Instructions ICR Form (Appendix A, B, C and D), Submission Method • ICR Form (Appendix A, B, C and D), Certification ICR Form (Appendix B and D), Certification • • • • • • Summary of Changes Type of Change Explanation of Changes Revisions throughout to include references to the CY 2027 final rule Revisions throughout to include references to applicable policies in the CY 2025 final rule Revisions to update the burden estimate to incorporate 2025 wage data Modify Technical updates Burden Change (Yes/No) No Modify Technical updates Yes Revisions to update the government burden estimate to incorporate 2026 federal pay scales Revisions to include references to applicable policies in the CY 2025 final rule Revised email address for submission of ICR Form Removed example deadlines specific to previous years Revised to specify “generic” drug manufacturer Revised email address for submission of updated authorized representative letter Modify Technical updates Yes Modify Technical updates No Modify Technical updates No Modify Technical updates No Modify Technical updates No References to section and question numbers reflect the lettering and numbering in the final document.